Plamsa 5=-AMP (pAMP) and uric acid (UA) elevated in type 2 diabetic

AMP-activated protein kinase α2 contributes to acute and chronic hyperuricemic nephropathy via renal urate deposition in a mouse model, European Journal of Medical Research

Nutrients, Free Full-Text

Recent advances in fructose intake and risk of hyperuricemia - ScienceDirect

Cells, Free Full-Text

AMPK alleviates high uric acid-induced Na+-K+-ATPase signaling impairment and cell injury in renal tubules

Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric A

Pharmacotherapy of type 2 diabetes: An update and future directions - ScienceDirect

AMP-activated protein kinase α2 contributes to acute and chronic hyperuricemic nephropathy via renal urate deposition in a mouse model, European Journal of Medical Research

Oral and Injectable (Non-Insulin) Pharmacological Agents for the Treatment of Type 2 Diabetes - Endotext - NCBI Bookshelf

The plasma 5′-AMP acts as a potential upstream regulator of hyperglycemia in type 2 diabetic mice